OnMonday, OpenAI released a set of proposals on the safety and security of cutting-edge artificial intelligence (AI) ...

TempusAI (TEM) and Recursion Pharmaceuticals (RXRX) extended their data license agreement through November 2029 and revised ...

Recursion Pharmaceuticals Inc. stocks have been trading up by 4.18 percent after positive AI-driven drug discovery progress fueled investor optimism. Key Takeaways A Form 4 filing disclosed changes in ...

Recursion Pharmaceuticals (RXRX) is back on traders’ screens after a sharp daily move, with the share price closing at ...

This in-depth analysis explores how OpenAI’s next-generation AI models prioritize recursive self-improvement as their core ...

Logan Kilpatrick said the feedback loop could help Google close the gap with other frontier AI labs with Gemini 4.

Outside the exhibit hall at Splunk .conf26 in Denver, Sunil Potti and I were talking about why he had come out of retirement.

Creation would no longer be only production. It would become a way of knowing. Another mind would be a mirror capable of ...

Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating ...

Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 8:30 AM EDTCompany ParticipantsNajat ...

AI Leaders Warn Recursive Self-Improvement Could Outpace Human Control The heads of leading U.S. AI labs made a rare show of unity over the weekend as they called for a pause in AI development. They w ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...